This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nanexa Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 24 shareholders own 55.15% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.5%	Novo Nordisk A/S	10,000,000	SEK 10.2m	0%	no data
6.87%	M2 Capital Management AB	4,167,194	SEK 4.3m	0%	0.07%
6.26%	Avanza Fonder AB	3,801,318	SEK 3.9m	0%	0.01%
5.8%	Jan Petersen	3,517,817	SEK 3.6m	0%	no data
4.37%	Skirner Förvaltning AB, Asset Management Arm	2,653,337	SEK 2.7m	0%	no data
3.85%	Applied Ventures, LLC	2,334,742	SEK 2.4m	0%	3.93%
3.33%	Nordnet AB (publ), Asset Management Arm	2,022,051	SEK 2.1m	0%	0.03%
2.37%	Jan Nordqvist	1,437,500	SEK 1.5m	0%	no data
1.74%	Mikael Jacobsson	1,055,089	SEK 1.1m	0%	no data
1.67%	David Olsson	1,011,050	SEK 1.0m	0%	no data
0.71%	Marten Rooth	432,000	SEK 440.6k	0%	no data
0.68%	Anders Johansson	410,250	SEK 418.5k	0%	no data
0.42%	Magnus Westgren	253,464	SEK 258.5k	0%	no data
0.19%	David Westberg	118,176	SEK 120.5k	0%	no data
0.099%	Eva Nilsagard	60,000	SEK 61.2k	0%	no data
0.099%	Urban Paulsson	60,000	SEK 61.2k	0%	no data
0.066%	Goran Ando	40,000	SEK 40.8k	0%	no data
0.053%	Bengt Gustavsson	32,000	SEK 32.6k	0%	no data
0.033%	Birgit Norinder	20,000	SEK 20.4k	0%	no data
0.025%	Kristine Bäck	15,000	SEK 15.3k	0%	no data
0.016%	Björn Svanström	10,000	SEK 10.2k	0%	no data
0.016%	Otto Skolling	9,600	SEK 9.8k	0%	no data
0.012%	Joel Hellrup	7,000	SEK 7.1k	0%	no data
0.006%	Mikael Asp	3,624	SEK 3.7k	0%	no data